Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS
· Delayed Price · Currency is USD
0.0651
-0.0100 (-13.27%)
At close: Dec 4, 2025
Altamira Therapeutics Employees
Altamira Therapeutics had 11 employees as of December 31, 2024. The number of employees increased by 1 or 8.65% compared to the previous year.
Employees
11
Change (1Y)
1
Growth (1Y)
8.65%
Revenue / Employee
n/a
Profits / Employee
-$513,903
Market Cap
371.79K
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
| Zomedica | 152 |
Altamira Therapeutics News
- 16 days ago - Altamira Therapeutics Announces Certification of Bentrio Nasal Spray under Medical Device Regulation - Accesswire
- 4 weeks ago - Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of DNA Molecules - Accesswire
- 3 months ago - Altamira Therapeutics Provides Business Update and First Half 2025 Financial Results - Accesswire
- 3 months ago - Altamira Therapeutics to Host First Half 2025 Financial Results and Business Update Call on August 29, 2025 - Accesswire
- 5 months ago - Altamira Therapeutics Announces Allowance of Japanese Patent Application Covering Intranasal Betahistine - Accesswire
- 6 months ago - Altamira Therapeutics Announces Collaboration on Circular RNA Delivery - GlobeNewsWire
- 7 months ago - Altamira Therapeutics Ltd. (CYTOF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 months ago - Altamira Therapeutics Provides Business Update, Reports Full Year 2024 Financial Results - GlobeNewsWire